Lancet Oncology

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world s best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three

Publisher
Elsevier
History
1823–present
Impact factor
33.633 (2010)
Some content from Wikipedia, licensed under CC BY-SA

The links between obesity and cancer

As the global cancer community convenes this week in Melbourne for the UICC World Cancer Congress, thousands of experts and cancer survivors are arriving into Australia to discuss, present and move this ...

Dec 03, 2014
popularity 5 / 5 (3) | comments 0

Concern at lack of teenage patients in cancer trials

Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), ...

Jun 30, 2014
popularity not rated yet | comments 0